9d ago
GLP-1/GIP Uptake, Indication, and Access Pathways Among US Adults in the Understanding America Study
Chaturvedi · R. R. · Gracner · T. · Perez-Arce · F. · Suen · S.-c. · +12 more
Abstract
Importance: Evidence on GLP-1/GIP therapies is largely derived from trials enrolling selected populations or medical records that miss utilization outside healthcare channels. No nationally representative cohort has characterized real-world uptake, indications, and access. Objective: To characterize GLP-1/GIP prevalence, indication, clinical profile, and access. Design: Prospective cohort study with three GLP-1/GIP surveillance waves (March 2024, December 2024, October 2025). Setting: The Unders
Discussion · 0
Sign in to join the discussion.